Fundraising Fox

RxAll

New Haven, US · Founded 2016 · Delaware corporation · 5 known investors

RxAll uses testing technology to detect counterfeit and substandard medicines, helping healthcare companies, pharmacies, and patients access verified high-quality drugs. It also offers financing and sales software for pharmacies and wholesalers, with a focus on Africa.

Founders & leadership

RxAll was founded in 2016 by Adebayo Alonge and Amy Kao.

AAAdebayo Alonge
Adebayo AlongeinFounder & CEO
AKAmy Kao
Amy KaoinCo-Founder & CMO

Board

DTDuncan Turner
Duncan Turnerin𝕏Board directorGeneral Partner at SOSV

Investors · 5

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 1 round · 2021

$2MraisedJun 2021 · 13 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Adebayo AlongeExecutive Officer, Director
  • Duncan TurnerDirector
  • Amy KaoDirector
Offering amount
$3M
Amount sold
$2M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with RxAll for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does RxAll do?
RxAll uses testing technology to detect counterfeit and substandard medicines, helping healthcare companies, pharmacies, and patients access verified high-quality drugs. It also offers financing and sales software for pharmacies and wholesalers, with a focus on Africa.
Who founded RxAll?
RxAll was founded by Adebayo Alonge, Amy Kao in 2016.
Who are RxAll's investors?
RxAll's investors include Founders Factory Africa, LoftyInc Capital, SOSV, HAX, Launch Africa Ventures.
How much funding has RxAll raised?
RxAll has disclosed $2M raised across 1 round.
Where is RxAll headquartered?
RxAll is headquartered in New Haven, US.